BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:00 AM
 | 
May 21, 2019
 |  BC Extra  |  Financial News

Sequoia leads digital therapeutics company Biofourmis' $35M round

Biofourmis raised $35 million in a series B round to develop its AI-powered digital therapeutics platform for improving patient outcomes.

The platform uses AI, drug intervention, wearable sensors and a smartphone app to remotely monitor and analyze a patient's physiological signals, and then predict and prevent adverse events before they occur.

Biofourmis Inc. (Boston, Mass.) said its lead product, BiovitalsHF, is the...

Read the full 289 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >